Adalimumab for the Management of Post-operative Crohn's Disease (CD)

NCT01629628 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Adalimumab
DRUG: 6 Mercaptopurine

Sponsor

Tel-Aviv Sourasky Medical Center

Collaborators

[object Object]